Lupus (SLE): vizsgálatok itt: Románia

In Románia 20 Also abroad 354

20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Where
Bucharest, Cluj-Napoca, Iași
Életkor
5 év to 80 év
People
1072 worldwide
Run by
AstraZeneca
See details and how to joinNCT07691970
3. fázisTaking people
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Where
Brasov, Bucharest, Cluj-Napoca
Életkor
12 év to 100 év
People
550 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06133972 · EU 2023-505929-14-00
3. fázisTaking people
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Where
Bucharest, Oradea
Életkor
18 év to 100 év
People
348 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06711887 · EU 2024-515280-60-00
3. fázisTaking people
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Where
Brasov, Bucharest
Életkor
18 év to 75 év
People
202 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07332481 · EU 2025-523871-44-00
3. fázisTaking people
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Where
Bucharest
Életkor
18 év to 75 év
People
202 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07355218 · EU 2025-524855-30-00
3. fázisTaking people
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Where
Brasov, Bucharest, Cluj-Napoca, Craiova, Oradea, Timisoara
Életkor
18 év to 75 év
People
600 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07438496 · EU 2025-523552-31-00
1. fázisTaking people
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Where
Bucharest, Cluj-Napoca
Életkor
18 év to 75 év
People
21 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00
2. fázisTaking people
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Where
Bucharest
Életkor
18 év to 74 év
People
405 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07409181 · EU 2025-523488-39-00
3. fázisNot yet taking people in Románia
Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Beneﬁted from Continued Treatment.
Where
Bucharest
People
340 worldwide
Run by
AstraZeneca AB
See details and how to join2026-526419-13-00 · EU 2026-526419-13-00
1. fázisTaking people
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Where
Bucharest, Cluj-Napoca
Életkor
18 év to 70 év
People
24 worldwide
Run by
Cullinan Therapeutics Inc.
See details and how to joinNCT06613360 · EU 2024-518780-36-00
3. fázisCsak meghívásos
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Where
Galati
Életkor
16 év and over
People
760 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT04976322 · EU 2023-506368-14-00
3. fázisCsak meghívásos
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
Where
Brasov, Bucharest, Cluj-Napoca, Iasi
Életkor
18 év and over
People
864 worldwide
Run by
Biogen
See details and how to joinNCT05352919 · EU 2023-505635-13-00
3. fázisTaking people
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-1)
Where
Bucharest, Craiova, Iasi, Râmnicu Vâlcea, Timisoara
Életkor
18 év and over
People
147 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2022-500699-76-00 · EU 2022-500699-76-00
3. fázisCsak meghívásos
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Where
Brasov, Bucharest
Életkor
18 év to 75 év
People
680 worldwide
Run by
Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00
3. fázisTaking people
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Where
Bucharest, Jassi, Oradea, Timisoara
Életkor
18 év to 75 év
People
300 worldwide
Run by
Viatris Innovation GmbH
See details and how to joinNCT07201129 · EU 2025-522984-14-00
1. fázisTaking people
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Where
Bucharest, Cluj-Napoca
Életkor
18 év and over
People
125 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00
1. fázisTaking people
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus
Where
Cluj-Napoca
Életkor
18 év and over
People
11 worldwide
Run by
Climb Bio Inc.
See details and how to join2024-520385-57-01 · EU 2024-520385-57-01
No phaseTaking people
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)
Where
Bucharest
Életkor
18 év and over
People
100
Run by
Stefan Lujinschi
See details and how to joinNCT07575347
1. fázisTaking people
A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Where
Cluj-Napoca
Életkor
18 év to 65 év
People
30 worldwide
Run by
Climb Bio, Inc.
See details and how to joinNCT07011043
4. fázisTaking people
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
Where
Bucharest
Életkor
18 év to 80 év
People
30
Run by
Institutul Clinic Fundeni
See details and how to joinNCT05207358